News

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.
Merck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.